Literature DB >> 7996132

Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein.

M Sapp1, U Kraus, C Volpers, P J Snijders, J M Walboomers, R E Streeck.   

Abstract

A panel of six monoclonal antibodies recognizing at least three different antigenic regions has been raised against the L1 major capsid protein of human papillomavirus type 33 (HPV-33), which is associated with cervical carcinoma. The antigenic sites defined by these antibodies have been mapped and classified as type-restricted or broadly cross-reactive using bacterially expressed L1 fusion proteins of a variety of HPV types. Conformational and linear epitopes have been distinguished using native and denatured virus-like particles. HPV infection of genital lesions has been analysed using both monoclonal antibodies and DNA amplification by PCR. The antibodies obtained should be useful to probe the structure of HPV capsids and to develop a general assay for the detection and classification of productive HPV infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996132     DOI: 10.1099/0022-1317-75-12-3375

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  46 in total

1.  Further evidence that papillomavirus capsids exist in two distinct conformations.

Authors:  Hans-Christoph Selinka; Tzenan Giroglou; Thorsten Nowak; Neil D Christensen; Martin Sapp
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Assembly and translocation of papillomavirus capsid proteins.

Authors:  Luise Florin; Cornelia Sapp; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

3.  Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70.

Authors:  Luise Florin; Katrin A Becker; Cornelia Sapp; Carsten Lambert; Hüseyin Sirma; Martin Müller; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes.

Authors:  Nadine Kämper; Patricia M Day; Thorsten Nowak; Hans-Christoph Selinka; Luise Florin; Jan Bolscher; Lydia Hilbig; John T Schiller; Martin Sapp
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Generation and neutralization of pseudovirions of human papillomavirus type 33.

Authors:  F Unckell; R E Streeck; M Sapp
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells.

Authors:  Carla Cerqueira; Pilar Samperio Ventayol; Christian Vogeley; Mario Schelhaas
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

7.  Human Papillomavirus Major Capsid Protein L1 Remains Associated with the Incoming Viral Genome throughout the Entry Process.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G M Guion; Timothy R Keiffer; Martin Sapp
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

8.  Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines.

Authors:  M Sapp; C Fligge; I Petzak; J R Harris; R E Streeck
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry.

Authors:  Gilles Spoden; Lena Kühling; Nicole Cordes; Bettina Frenzel; Martin Sapp; Klaus Boller; Luise Florin; Mario Schelhaas
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

10.  Target cell cyclophilins facilitate human papillomavirus type 16 infection.

Authors:  Malgorzata Bienkowska-Haba; Hetalkumar D Patel; Martin Sapp
Journal:  PLoS Pathog       Date:  2009-07-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.